Skip to main content
PREVIEW · SAMPLE DATA
This is the SLXN dossier with made-up numbers. Sign up free to see live prices, insider trades, 13F flows and fundamentals for SLXN.

SLXN

Silexion Therapeutics Corp
Healthcare · Biotechnology
$89.34 sample
+0.83 (+0.94%) 1D
☆ Watch
Market cap
$419.9B
Price as of
2026-10-29
Latest filing
8-K · 2026-10-22
Alerts
8
Price$89.34 +9.81% 3M daily closessample
90.6280.99
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first
  • Oct 22SECDEF 14A filed
  • Oct 19SECDEF 14A filed
  • Oct 12INSInsider sell: Director
  • Oct 01SECForm 144 filed
  • Sep 25INSInsider sell: Chief Financial Officer
  • Sep 16SEC10-Q filed
  • Sep 10INSInsider sell: Director
  • Sep 04INSInsider buy: EVP, Operations
Sign up to see the real SLXN record →

Company facts

SEC EDGAR registration
Name
Silexion Therapeutics Corp
Sector
Healthcare
Industry
Biotechnology
Smart-money score
-40sample, -100 to +100
Reporting currency
USD

Who is positioning in SLXN

sample
Insiders
10 insider transactions over 90 days, net selling, $266.8M
Congress
No member trades over 90 days
Institutions · 13F
12 funds hold $6.0B
Activists · 13D/G
No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end
Revenue$26.6B +17.3% y/y
Q4 2024Q3 2026
Inventory$15.5B +15.2% y/y
Q4 2024Q3 2026
Accounts receivable$11.5B +8.7% y/y
Q4 2024Q3 2026
Total debt$32.1B +17.8% y/y
Q4 2024Q3 2026

Peers

sample
Sample peer A
$281.4B -9.6% 3M
Sample peer B
$107.0B -0.2% 3M
Sample peer C
$161.1B +10.6% 3M
Sample peer D
$67.0B +7.0% 3M
Sample peer E
$159.4B +13.7% 3M
Preview. Company name, sector and industry are from SEC EDGAR; every price, flow, filing count and fundamental on this page is sample data generated for the preview and is not SLXN's real figure. Nothing here is investment advice.